"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
- Clinician Information:
Ethamolin Patient Information including How Should I Take
In this Article
- What is ethanolamine oleate (Ethamolin)?
- What are the possible side effects of ethanolamine oleate (Ethamolin)?
- What is the most important information I should know about ethanolamine oleate (Ethamolin)?
- What should I discuss with my health care provider before receiving ethanolamine oleate (Ethamolin)?
- How is ethanolamine oleate given (Ethamolin)?
- What happens if I miss a dose (Ethamolin)?
- What happens if I overdose (Ethamolin)?
- What should I avoid while receiving ethanolamine oleate (Ethamolin)?
- What other drugs will affect ethanolamine oleate (Ethamolin)?
- Where can I get more information?
What should I discuss with my health care provider before receiving ethanolamine oleate (Ethamolin)?
You should not use this medication if you are allergic to ethanolamine oleate or oleic acid (oleo).
Ethanolamine oleate will not treat any underlying liver disease.
If possible, before you receive ethanolamine oleate, tell your doctor if you are allergic to any drugs, or if you have:
- kidney disease;
- heart disease; or
- lung disease.
If you have any of these conditions, you may need dose adjustments or special tests during treatment.
FDA pregnancy category C. It is not known whether ethanolamine oleate is harmful to an unborn baby. Before you receive this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether ethanolamine oleate passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
In an emergency situation, it may not be possible before you are treated with ethanolamine oleate to tell your caregivers if you are pregnant or breast-feeding. However, make sure any doctor caring for your pregnancy or your baby knows that you have received this medication.
How is ethanolamine oleate given (Ethamolin)?
Ethanolamine oleate is given as an injection through a needle placed directly into the vein. You will receive this injection in a hospital or emergency setting.
This medication is usually given during a bleeding episode and again at 1 week, 6 weeks, 3 months, and 6 months afterward.
Additional Ethamolin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.